Ekinops SA
PAR:EKI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ekinops SA
PAR:EKI
|
FR |
|
Wynnstay Properties PLC
LSE:WSP
|
UK |
|
N
|
Novo Nordisk A/S
XBER:NOV
|
DK |
|
China Nonferrous Gold Ltd
LSE:CNG
|
KY |
|
G
|
Greenland Resources Inc
OTC:GRLRF
|
CA |
|
H
|
Havila Kystruten AS
OSE:HKY
|
NO |
|
O
|
Opal Fuels Inc
NASDAQ:OPAL
|
US |
|
P
|
Psybio Therapeutics Corp
XTSX:PSYB
|
CA |
|
ABC Arbitrage SA
OTC:ABCCF
|
FR |
Wall Street
Price Targets
EKI Price Targets Summary
Ekinops SA
According to Wall Street analysts, the average 1-year price target for
EKI
is 3.06 EUR
with a low forecast of 2.121 EUR and a high forecast of 5.985 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EKI's stock price target?
Price Target
3.06
EUR
According to Wall Street analysts, the average 1-year price target for
EKI
is 3.06 EUR
with a low forecast of 2.121 EUR and a high forecast of 5.985 EUR.
What is Ekinops SA's Revenue forecast?
Projected CAGR
3%
For the last 12 years the
compound annual growth rate for
Ekinops SA's revenue is
23%.
The projected
CAGR
for the next 4 years is
3%.
What is Ekinops SA's Operating Income forecast?
Projected CAGR
-42%
The
compound annual growth rate
of
Ekinops SA's operating income for the next 3 years is
-42%.